These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12663227)

  • 1. Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins.
    Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H
    J Hepatol; 2003 Apr; 38(4):387-94. PubMed ID: 12663227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid-induced Mallory body formation in drug-primed mouse liver.
    Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H
    Am J Pathol; 2002 Dec; 161(6):2019-26. PubMed ID: 12466118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratins as targets for bile acid-induced toxicity.
    Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H
    Am J Pathol; 2002 Feb; 160(2):491-9. PubMed ID: 11839569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
    Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A
    Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor.
    Nan L; Dedes J; French BA; Bardag-Gorce F; Li J; Wu Y; French SW
    Exp Mol Pathol; 2006 Jun; 80(3):228-40. PubMed ID: 16563375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies.
    Preisegger KH; Zatloukal K; Spurej G; Denk H
    Liver; 1991 Oct; 11(5):300-9. PubMed ID: 1720496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice.
    Cadrin M; Anderson NM; Aasheim LH; Kawahara H; Franks DJ; French SW
    Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretory function in cultured hepatocytes from griseofulvin-treated mice.
    Kawahara H; Marceau N; French SW
    Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mallory body as an aggresome: in vitro studies.
    Riley NE; Li J; Worrall S; Rothnagel JA; Swagell C; van Leeuwen FW; French SW
    Exp Mol Pathol; 2002 Feb; 72(1):17-23. PubMed ID: 11784119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the ubiquitin-proteasome pathway in the formation of mallory bodies.
    Bardag-Gorce F; van Leeuwen FW; Nguyen V; French BA; Li J; Riley N; McPhaul LW; Lue YH; French SW
    Exp Mol Pathol; 2002 Oct; 73(2):75-83. PubMed ID: 12231209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo expression of nonhepatocellular cytokeratins in Mallory body formation.
    Schirmacher P; Dienes HP; Moll R
    Virchows Arch; 1998 Feb; 432(2):143-52. PubMed ID: 9504859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes.
    Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW
    Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of cytokeratin intermediate filaments by calcium-activated proteases (calpains) in vitro: implications for formation of Mallory bodies.
    Makowski GS; Ramsby ML
    Res Commun Mol Pathol Pharmacol; 1998 Sep; 101(3):211-23. PubMed ID: 9874279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence of events in the assembly of Mallory body components in mouse liver: clues to the pathogenesis and significance of Mallory body formation.
    Stumptner C; Fuchsbichler A; Lehner M; Zatloukal K; Denk H
    J Hepatol; 2001 May; 34(5):665-75. PubMed ID: 11434612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mallory body filaments become insoluble after normal assembly into intermediate filaments.
    Pollanen MS; Markiewicz P; Weyer L; Goh MC; Bergeron C
    Am J Pathol; 1994 Nov; 145(5):1140-7. PubMed ID: 7526693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation.
    Bardag-Gorce F; Riley NE; Nan L; Montgomery RO; Li J; French BA; Lue YH; French SW
    Exp Mol Pathol; 2004 Feb; 76(1):9-16. PubMed ID: 14738863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis.
    Yabushita K; Yamamoto K; Ibuki N; Okano N; Matsumura S; Okamoto R; Shimada N; Tsuji T
    Liver; 2001 Feb; 21(1):50-5. PubMed ID: 11169073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
    Crosby HA; Hubscher S; Fabris L; Joplin R; Sell S; Kelly D; Strain AJ
    Am J Pathol; 1998 Mar; 152(3):771-9. PubMed ID: 9502419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
    Zollner G; Fickert P; Silbert D; Fuchsbichler A; Marschall HU; Zatloukal K; Denk H; Trauner M
    J Hepatol; 2003 Jun; 38(6):717-27. PubMed ID: 12763363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-histochemical studies of griseofulvin-intoxicated mouse livers.
    Woltsche M; Zatloukal K; Denk H
    Liver; 1991 Aug; 11(4):231-40. PubMed ID: 1658525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.